Medistim Logo

Medistim ist ein norwegischer Hersteller und Anbieter von Medizintechnikprodukten. Der Schwerpunkt des Unternehmens liegt auf intraoperativen Qualitätskontrollanwendungen für die Herz-, Transplantations- und Gefäßchirurgie. Innerhalb dieser Nische nimmt Medistim derzeit annähernd eine Monopolstellung ein. Die Kombination aus TTFM-Technologie (transit time flow measurement) und Ultraschallbildgebung machen deren Produkte VeriQ-C sowie MiraQ einzigartig und werden daher auch von den führenden Guidelines für die Anwendung bei Bypass-Operationen empfohlen.   

Unsere Aktienanalysen

News zu Medistim

  • Company Presentation April 2020
    von Benedicte Meydel am 01/04/2020 um 09:38

    The post Company Presentation April 2020 appeared first on Medistim.

  • Annual Report 2019
    von Benedicte Meydel am 27/03/2020 um 14:28

    We have now achieved a market penetration of 23% in USA, measured as the share of bypass procedures done with Medistim’s devices. Our position in Asia and Europe is also strengthened, through increased sales and installed base. During 2019, the multi center registry study – REQUEST – received a lot of positive attention. Some of The post Annual Report 2019 appeared first on Medistim.

  • The REQUEST study is now published
    von Benedicte Meydel am 24/03/2020 um 09:09

    The REQUEST study is a multicenter, prospective study among 7 international centers performing coronary artery bypass grafting procedures.  The primary endpoint was any change in the planned surgical procedure. Major secondary endpoints consisted of the rate and reason for surgical changes related to the aorta, in situ conduits, coronary targets, and completed grafts, and the The post The REQUEST study is now published appeared first on Medistim.

  • Results for Fourth Quarter and Preliminary Results for Medistim for 2019
    von Benedicte Meydel am 28/02/2020 um 10:33

    Sales for the quarter ended at MNOK 95.7 (MNOK 97.9), while sales for 2019 ended at MNOK 363.7 (MNOK 325.9), a growth of 11.6%. Q4 2019 PresentationQ4 and preliminary year-end financials 2019 The post Results for Fourth Quarter and Preliminary Results for Medistim for 2019 appeared first on Medistim.

  • Investor Presentation, March 3
    von Benedicte Meydel am 25/02/2020 um 15:23

    Medistim’s CEO Kari E. Krogstad will hold an investor presentation at the Carnegie Healthcare Seminar 2020 in Stockholm, Sweden. Date: Tuesday March 3, 2020 Venue: Regeringsgatan 56. 103 38 Stockholm For more information about this seminar, contact https://www.carnegie.se/en/ The post Investor Presentation, March 3 appeared first on Medistim.